Blackstone Group »

Artiva Biotherapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $23M 2.4M 9.70

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Digital Realty Trust (DLR)
Corebridge Finl (CRBG)
Legence Corp Cl A (LGN)
FirstEnergy (FE)
Williams Companies (WMB)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Kinder Morgan (KMI)
Enbridge (ENB)
MPLX Com Unit Rep Ltd (MPLX)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)

View all positions for Blackstone Group

Top funds holding Artiva Biotherapeutics

RA Capital Management
Viking Global Investors
Blackstone Group
5AM Venture Management
VR Adviser
Franklin Resources
Caligan Partners
Vanguard Capital Management
Samsara BioCapital
Blue Owl Capital Holdings
Propel Bio Management
BlackRock
Citadel Advisors
Silverarc Capital Management
Geode Capital Management

View all funds holding Artiva Biotherapeutics